Home Cart 0 Sign in  

[ CAS No. 14508-49-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 14508-49-7
Chemical Structure| 14508-49-7
Structure of 14508-49-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 14508-49-7 ]

Related Doc. of [ 14508-49-7 ]

Alternatived Products of [ 14508-49-7 ]

Product Details of [ 14508-49-7 ]

CAS No. :14508-49-7 MDL No. :MFCD00006124
Formula : C4H3ClN2 Boiling Point : -
Linear Structure Formula :- InChI Key :GELVZYOEQVJIRR-UHFFFAOYSA-N
M.W : 114.53 Pubchem ID :73277
Synonyms :

Calculated chemistry of [ 14508-49-7 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 27.04
TPSA : 25.78 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.5 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.15
Log Po/w (XLOGP3) : 0.7
Log Po/w (WLOGP) : 1.13
Log Po/w (MLOGP) : -0.25
Log Po/w (SILICOS-IT) : 1.74
Consensus Log Po/w : 0.89

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.63
Solubility : 2.71 mg/ml ; 0.0237 mol/l
Class : Very soluble
Log S (Ali) : -0.82
Solubility : 17.4 mg/ml ; 0.152 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.21
Solubility : 0.705 mg/ml ; 0.00615 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.8

Safety of [ 14508-49-7 ]

Signal Word:Danger Class:3
Precautionary Statements:P501-P240-P210-P233-P243-P241-P242-P264-P280-P370+P378-P337+P313-P305+P351+P338-P362+P364-P303+P361+P353-P332+P313-P403+P235 UN#:1993
Hazard Statements:H225-H315-H319 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 14508-49-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 14508-49-7 ]
  • Downstream synthetic route of [ 14508-49-7 ]

[ 14508-49-7 ] Synthesis Path-Upstream   1~59

  • 1
  • [ 14508-49-7 ]
  • [ 124-41-4 ]
  • [ 3149-28-8 ]
Reference: [1] Synthesis, 1996, # 7, p. 838 - 842
[2] Journal of the Chemical Society, 1956, p. 1294,1399
  • 2
  • [ 14508-49-7 ]
  • [ 865-33-8 ]
  • [ 6542-37-6 ]
  • [ 870071-00-4 ]
  • [ 3149-28-8 ]
Reference: [1] Tetrahedron, 2006, vol. 62, # 31, p. 7319 - 7338
  • 3
  • [ 14508-49-7 ]
  • [ 4774-14-5 ]
Reference: [1] Patent: US2797219, 1955, ,
  • 4
  • [ 14508-49-7 ]
  • [ 7782-50-5 ]
  • [ 4774-14-5 ]
Reference: [1] Patent: US2797219, 1955, ,
  • 5
  • [ 16025-16-4 ]
  • [ 14508-49-7 ]
  • [ 4858-85-9 ]
  • [ 4774-14-5 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1984, # 10, p. 2860 - 2875
  • 6
  • [ 6863-76-9 ]
  • [ 14508-49-7 ]
  • [ 19745-07-4 ]
  • [ 4858-85-9 ]
  • [ 4774-14-5 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1984, # 10, p. 2860 - 2875
  • 7
  • [ 290-37-9 ]
  • [ 7732-18-5 ]
  • [ 7782-50-5 ]
  • [ 14508-49-7 ]
  • [ 19745-07-4 ]
  • [ 4858-85-9 ]
  • [ 4774-14-5 ]
Reference: [1] Patent: US2540476, 1948, ,
  • 8
  • [ 14508-49-7 ]
  • [ 6270-63-9 ]
Reference: [1] Journal of the American Chemical Society, 1946, vol. 68, p. 400
  • 9
  • [ 14508-49-7 ]
  • [ 56423-63-3 ]
Reference: [1] European Journal of Organic Chemistry, 2002, # 24, p. 4181 - 4184
  • 10
  • [ 14508-49-7 ]
  • [ 5049-61-6 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 14, p. 3734 - 3737
[2] Journal of the American Chemical Society, 1946, vol. 68, p. 400
[3] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 3, p. 1137 - 1140
  • 11
  • [ 14508-49-7 ]
  • [ 5049-61-6 ]
  • [ 533930-18-6 ]
Reference: [1] Organometallics, 2017, vol. 36, # 2, p. 251 - 254
  • 12
  • [ 2423-65-6 ]
  • [ 14508-49-7 ]
  • [ 5049-61-6 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1984, vol. 57, # 10, p. 3015 - 3016
  • 13
  • [ 288-32-4 ]
  • [ 67-66-3 ]
  • [ 14508-49-7 ]
  • [ 17180-94-8 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1427 - 1430
  • 14
  • [ 67-66-3 ]
  • [ 18156-74-6 ]
  • [ 14508-49-7 ]
  • [ 17180-94-8 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1427 - 1430
  • 15
  • [ 616-47-7 ]
  • [ 67-66-3 ]
  • [ 14508-49-7 ]
  • [ 4513-94-4 ]
  • [ 17180-94-8 ]
  • [ 51269-82-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 16
  • [ 616-47-7 ]
  • [ 67-66-3 ]
  • [ 14508-49-7 ]
  • [ 17180-94-8 ]
  • [ 89809-64-3 ]
  • [ 51269-82-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 17
  • [ 616-47-7 ]
  • [ 67-66-3 ]
  • [ 14508-49-7 ]
  • [ 17180-94-8 ]
  • [ 51269-82-0 ]
  • [ 38180-46-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 18
  • [ 616-47-7 ]
  • [ 67-66-3 ]
  • [ 14508-49-7 ]
  • [ 17180-94-8 ]
  • [ 51269-82-0 ]
  • [ 68325-15-5 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 19
  • [ 14508-49-7 ]
  • [ 557-21-1 ]
  • [ 19847-12-2 ]
Reference: [1] Organic Letters, 2007, vol. 9, # 9, p. 1711 - 1714
  • 20
  • [ 14508-49-7 ]
  • [ 557-21-1 ]
  • [ 19847-12-2 ]
Reference: [1] Organic Letters, 2017, vol. 19, # 8, p. 2118 - 2121
  • 21
  • [ 14508-49-7 ]
  • [ 19847-12-2 ]
Reference: [1] Arkivoc, 2010, vol. 2010, # 6, p. 47 - 52
  • 22
  • [ 14508-49-7 ]
  • [ 143-33-9 ]
  • [ 19847-12-2 ]
Reference: [1] Synthetic Communications, 2001, vol. 31, # 14, p. 2203 - 2207
  • 23
  • [ 6863-76-9 ]
  • [ 14508-49-7 ]
  • [ 19745-07-4 ]
  • [ 4858-85-9 ]
  • [ 4774-14-5 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1984, # 10, p. 2860 - 2875
  • 24
  • [ 290-37-9 ]
  • [ 7732-18-5 ]
  • [ 7782-50-5 ]
  • [ 14508-49-7 ]
  • [ 19745-07-4 ]
  • [ 4858-85-9 ]
  • [ 4774-14-5 ]
Reference: [1] Patent: US2540476, 1948, ,
  • 25
  • [ 14508-49-7 ]
  • [ 4858-85-9 ]
Reference: [1] Journal of Organic Chemistry, 2005, vol. 70, # 7, p. 2616 - 2621
[2] Journal of Heterocyclic Chemistry, 1981, vol. 18, p. 405 - 407
  • 26
  • [ 16025-16-4 ]
  • [ 14508-49-7 ]
  • [ 4858-85-9 ]
  • [ 4774-14-5 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1984, # 10, p. 2860 - 2875
  • 27
  • [ 6863-76-9 ]
  • [ 14508-49-7 ]
  • [ 19745-07-4 ]
  • [ 4858-85-9 ]
  • [ 4774-14-5 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1984, # 10, p. 2860 - 2875
  • 28
  • [ 290-37-9 ]
  • [ 7732-18-5 ]
  • [ 7782-50-5 ]
  • [ 14508-49-7 ]
  • [ 19745-07-4 ]
  • [ 4858-85-9 ]
  • [ 4774-14-5 ]
Reference: [1] Patent: US2540476, 1948, ,
  • 29
  • [ 616-47-7 ]
  • [ 67-66-3 ]
  • [ 14508-49-7 ]
  • [ 17180-94-8 ]
  • [ 89809-64-3 ]
  • [ 51269-82-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 30
  • [ 616-47-7 ]
  • [ 67-66-3 ]
  • [ 14508-49-7 ]
  • [ 4513-94-4 ]
  • [ 17180-94-8 ]
  • [ 51269-82-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 31
  • [ 616-47-7 ]
  • [ 67-66-3 ]
  • [ 14508-49-7 ]
  • [ 17180-94-8 ]
  • [ 89809-64-3 ]
  • [ 51269-82-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 32
  • [ 616-47-7 ]
  • [ 67-66-3 ]
  • [ 14508-49-7 ]
  • [ 17180-94-8 ]
  • [ 51269-82-0 ]
  • [ 38180-46-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 33
  • [ 616-47-7 ]
  • [ 67-66-3 ]
  • [ 14508-49-7 ]
  • [ 17180-94-8 ]
  • [ 51269-82-0 ]
  • [ 68325-15-5 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 34
  • [ 14508-49-7 ]
  • [ 141-52-6 ]
  • [ 38028-67-0 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 5, p. 887 - 890
[2] Journal of the American Chemical Society, 1946, vol. 68, p. 400
  • 35
  • [ 14508-49-7 ]
  • [ 64-17-5 ]
  • [ 38028-67-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1986, p. 1255 - 1258
  • 36
  • [ 14508-49-7 ]
  • [ 67-56-1 ]
  • [ 201230-82-2 ]
  • [ 6164-79-0 ]
Reference: [1] Organic Letters, 2004, vol. 6, # 13, p. 2097 - 2100
[2] Synthesis, 1990, vol. 1, # 10, p. 923 - 924
[3] Synthesis, 1990, vol. 1, # 10, p. 923 - 924
  • 37
  • [ 14508-49-7 ]
  • [ 77287-34-4 ]
  • [ 21279-62-9 ]
YieldReaction ConditionsOperation in experiment
25% at 90℃; for 26 h; The starting compound 3-chloropyrazine-2-carboxamide was synthesized using two published procedures. The first method was classified as less effective and was based on the homolytic amidation of 2-chloropyrazine. Thus, 2-chloropyrazine (0.17 mol) was dissolved in formamide (3.7 mol), heated to 90 °C and ammonium peroxodisulphate (0.18 mol) was added portionwise over one hour period. This mixture reacted for another one hour at 90 °C and then it was left to stand for 24 h at laboratory temperature. Dilution with 100 mL of water was followed by filtration and this filtrate was extracted continuously with chloroform for 16 h [34,42]. The mixture of three positional isomers was separated by flash chromatography using silica gel as stationary phase. The second process used 3-chloropyrazine-2-carbonitrile, which was submitted to partial hydrolysis of the nitrile group. The powdered carbonitrile (0.104 mol) was added little by little into the reaction mixture of concentrated hydrogen peroxide (0.95 mol) and water (195 mL) heated to 50 °C. The pH was adjusted and regulated around a value of 9 using an 8percent solution of sodium hydroxide and the temperature of the reaction was regulated between 55 and 60 °C. The reaction was stopped after 2.5 h and was cooled to 5 °C. Newly-emerged crystals were removed by suction and recrystallized from ethanol [42].
Reference: [1] Molecules, 2014, vol. 19, # 7, p. 9318 - 9338
  • 38
  • [ 14508-49-7 ]
  • [ 77287-34-4 ]
  • [ 21279-62-9 ]
  • [ 36070-79-8 ]
  • [ 21279-64-1 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1990, vol. 55, # 10, p. 2493 - 2501
[2] Collection of Czechoslovak Chemical Communications, 1990, vol. 55, # 10, p. 2493 - 2501
  • 39
  • [ 616-47-7 ]
  • [ 67-66-3 ]
  • [ 14508-49-7 ]
  • [ 17180-94-8 ]
  • [ 51269-82-0 ]
  • [ 38180-46-0 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 40
  • [ 616-47-7 ]
  • [ 67-66-3 ]
  • [ 14508-49-7 ]
  • [ 17180-94-8 ]
  • [ 51269-82-0 ]
  • [ 68325-15-5 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1431 - 1435
  • 41
  • [ 14508-49-7 ]
  • [ 32111-21-0 ]
YieldReaction ConditionsOperation in experiment
60%
Stage #1: With acetic acid; sodium iodide In acetonitrile for 4.5 h; Reflux
Stage #2: With sodium hydrogencarbonate In water
A reaction mixture of chloropyrazine (7.5 ml, 83 mmol), NaI (30.3 g, 202 15 mmol), HOAc (9.6 ml, 168 mmol) and H2SO4 (0.5 ml) in MeCN (105 ml) was heated at reflux for 4.5 hours. The solvent was removed and water (120 ml) was added. After the solution was basified with saturated NaHCO3, it was extracted with dichloromethane (DCM) (2 x 125 ml). The DCM layers were combined, washed with saturated Na2S2O3, brine and dried. The removal of solvent gave crude iodopyrazine as an oil (12.33 g, 20 71percent). Analysis by 1H NMR showed there was less than about 10 molpercent of chloropyrazine in the oil. Another batch of chloropyrazine (50 g, 437 mmol) was also converted into crude iodopyrazine (about 65 g) by the same procedure. These two batches of crude iodopyrazine were combined and distillation of the crude iodopyrazine under reduced pressure (about 0.75 torr, bp 47°C) gave pure compound 64 g (60percent). 251H-NMR (CDCl3, 300MHz) 8.40 (dd, /=1.8, 2.4Hz, IH), 8.51 (d, /=2.4Hz,lH), 8.87 (d, /=1.5Hz,lH).
Reference: [1] Tetrahedron, 1998, vol. 54, # 33, p. 9701 - 9710
[2] Patent: WO2009/114313, 2009, A2, . Location in patent: Page/Page column 15
  • 42
  • [ 14508-49-7 ]
  • [ 10034-85-2 ]
  • [ 32111-21-0 ]
YieldReaction ConditionsOperation in experiment
65% With sodium iodide In water; acetone EXAMPLE 1
This Example illustrates the preparation of 2-iodopyrazine.
2-Chloropyrazine (6.18 g, 54 mmol) was added to a saturated solution of sodium iodide in acetone (100 ml) and water (3 ml) at reflux temperature under a nitrogen atmosphere.
A solution of hydroiodic acid (3 ml of 55) in water (6 ml) was added and the mixture was heated at reflux temperature for 19 hours.
The precipitated solids were removed by filtration and the filtrate concentrated under reduced pressure.
Water (100 ml) was added to the residue and then solid sodium sulphite until a negative starch iodide test was obtained.
Sodium hydroxide pellets were added until the pH was greater than pH 11 and the mixture was continuously extracted with diethylether.
The extract was concentrated under reduced pressure and the residue fractionated to give the product as a clear oil (65percent, b. pt. 83°-85° C./18 mm Hg).
NMR (90 MHz, CDCl3): 8,88 (1H,m), 8.53 (1H,m), 8.40 (1H, m).
m/z: 206 (M+), 127, 79 (100percent).
Reference: [1] Patent: US4975112, 1990, A,
  • 43
  • [ 14508-49-7 ]
  • [ 2234-82-4 ]
  • [ 18138-03-9 ]
YieldReaction ConditionsOperation in experiment
82.4%
Stage #1: With iron(III)-acetylacetonate In tetrahydrofuranInert atmosphere
Stage #2: Cooling with ice-water
Stage #3: With ammonium chloride In tetrahydrofuran; water at 20℃; Inert atmosphere
EXAMPLE 1Synthesis of the compound of Formula I5 2-[4-(7-Ethyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)- phenyl]-propan-2-ol. 80 - 95percent2-chloropyrazine 2-n-propylpyrazineKHMDS4-acetylbenzonitrile 4-(1-hydroxy-1-methylethyl)benzonitrile TBME 70percentFormula IScheme 2The title compound was synthesized by the reactions of Scheme 2, shown above. 2-Propylpyrazine was first prepared by the following. This was accomplished by adding to a stirred round bottom flask 8.0 mL of 2-chloropyrazine, 1.58 g Fe(acac)3 (also known as iron acetylacetonate) and 100 mL THF (tetrahydrofuran). This was stirred under nitrogen giving a red solution. The flask was cooled in an ice-water bath for ten minutes. Then the addition of 49 mL of n-propylmagnesium chloride to the flask was begun. This resulted in a dark purple solution. After 1.5 hours 10 mL of n-propylmagnesium chloride were added over ten minutes. After an additional 20 minutes, an additional 5 mL of n-propylmagnesium chloride were added. After about 30 minutes of stirring, 22 mL of saturated aqueous NH4Cl were added over 7 minutes. After an additional 7 mL of the NH4Cl were added, the stirring was stopped and the mixture was allowed to stand at room temperature overnight under nitrogen.After adding 125 mL EtOAc and 450 mL water, the contents of the flask were filtered through polypropylene and poured into a separatory funnel. The phases were separated, and the aqueous phase was extracted twice more with 125 mL portions of EtOAc. The combined organic phase was filtered through Celite.(R). and subsequently concentrated by rotary evaporation (200 mbar, 40 0C). After a short-path distillation, the distillate was distilled (200 mbar, 90-110 0C) through a Vigreux column to give 9.0 g (82.4percent yield) of 2-n- propylpyrazine. HPLC of the final product gave a retention time of 3.0 minutes using an Elipse XDB-C8 column, 4.6 x 150 mm, 5 microns, using 60:40 acetonitrile/water, with 1percent TFA, isocratically at 1 niL/minute at 350C.
Reference: [1] Patent: WO2010/107969, 2010, A1, . Location in patent: Page/Page column 6-7
[2] Journal of the American Chemical Society, 1992, vol. 114, # 13, p. 5269 - 5280
[3] Organic Process Research and Development, 2015, vol. 19, # 7, p. 806 - 811
  • 44
  • [ 14508-49-7 ]
  • [ 4949-13-7 ]
Reference: [1] Tetrahedron, 1998, vol. 54, # 19, p. 4899 - 4912
[2] Chemistry Letters, 1993, # 3, p. 509 - 512
[3] Heterocycles, 1992, vol. 34, # 8, p. 1507 - 1510
[4] Angewandte Chemie - International Edition, 2006, vol. 45, # 17, p. 2720 - 2725
[5] Organic Letters, 2015, vol. 17, # 8, p. 1866 - 1869
[6] Journal of Organic Chemistry, 2015, vol. 80, # 24, p. 12137 - 12145
  • 45
  • [ 14508-49-7 ]
  • [ 54608-52-5 ]
YieldReaction ConditionsOperation in experiment
75% With hydrazine hydrate In water at 63 - 65℃; Step 1: 2-hydrazinylpyrazine [0204] 2-Chloropyrazine (2.0 g, 17.5 mmol) was added dropwise to a 35percent aqueous solution of hydrazine hydrate (25.8 g, 97.8 mmol) at 63-65 °C, the addition rate was carefully monitored to ensure that the reaction temperature did not exceed 65 °C. Following the addition, the mixture was heated to 65 °C. After stirring overnight, the reaction was cooled to room temperature. The solvent was evaporated to afford the title compound as a yellow powder (1.5 g, 75percent). MS (ESI) calcd for C4H6N4: 110.1; found: 111.4 [M+H]. *H NMR (400 MHz, CD3OD) δ 8.10 (d, J = 1.6 Hz, 1H), 8.00 (dd, J = 3.2, 1.6 Hz, 1H), 7.73(d, J = 3.2 Hz, 1H).
67% at 100℃; for 2 h; General procedure: (0.1mole) of 2-halo nitrogen heterocycle and (0.5 mole) of hydrazine hydrate were mixed together in a 250mL round bottom flask equipped with reflux condenser and wereheated at 100oC, progress of the reaction was monitored byTLC. After completion of the reaction the reaction mixture was cooled to (-5-0oC) for 14hr and the precipitated solid was filtered and washed with two 5ml portions of ice coldwater and dried to give the compound 1 in good yield.
60% at 20 - 110℃; for 1 h; A mixture of 2-chloropyrazine (4.00 g) andhydrazine hydrate was heated at 1 10 °C for 1 h, and then cooled to room temperature. The mixture was filtered to give the title compound as a solid (2.30 g, 60.00 percent). The compound was characterized by the following spectroscopic data: MS (ESI, pos. ion) m/z: 1 1 1.0 (M+ l).
60% at 110℃; for 1 h; A mixture of 2-chloropyrazine (4.00 g) and hydrazine hydrate was heated at 110° C. for 1 h, and then cooled to room temperature. The mixture was filtered to give the title compound as a solid (2.30 g, 60.00percent). The compound was characterized by the following spectroscopic data: MS (ESI, pos. ion) m/z: 111.0 (M+1).
60.5% at 60℃; for 10 h; 1)Will be 31.3 grams(80 wtpercent, 50 mmol)Hydrazine hydrate was added to 100 ml three-necked flask,Heating up to 60 ,Under magnetic stirring, 11.5 g was slowly added dropwise(100 mmol)2-chloropyrazine,The reaction was carried out at a temperature of 60 ° C for 10 hours,After completion of the reaction, the mixture was cooled to 2 ° C,Precipitation of solids,filter,Dried to afford 6.63 g of a white solid,Yield 60.5percent;
51% With hydrazine In water at 20 - 67℃; for 53 h; Inert atmosphere The reaction was run under nitrogen atmosphere. 2-chloropyrazine (96 mL, 1073 mmol) was added dropwise to 35 wt aqueous hydrazine (544 mL, 6009 mmol) at 65 °C over 1 h. After the addition, stirring was continued at 63-67 °C for 16 h then let stand at room temperature for two days. The mixture was filtered to remove a small amount of precipitate, then extracted with 10percent iPrOH/dichloromethane (5 x 250 mL). The combined organic extracts were dried (MgS04), filtered, then concentrated under reduced pressure. The resulting solid was triturated with isopropyl acetate (600 mL). The solid was collected by filtration, rinsed with isopropyl acetate and dried under vacuum to give 2-hydrazinylpyrazine (60 g, 51 percent) as a pale yellow solid. LCMS m/z = 111.2 [M+H]+. lU NMR (400 MHz, DMSO-i ) δ 4.21 (s, 2H), 7.70 (d, = 2.8 Hz, 1H), 7.89 (s, 1H), 7.93 (dd, = 2.8, 1.5 Hz, 1H), 8.10 (d, = 1.5 Hz, 1H).
47% With hydrazine In ethanol at 20℃; for 17 h; Heating / reflux [Referential Example 33] 2-Hydrazinopyrazine; [Show Image] Hydrazine monohydrate (21.80 g) was added to a solution of 2-chloropyrazine (10.44 g) in ethanol (65 ml) at room temperature, and the mixture was heated under reflux for 17 hours. After cooling with air, the reaction solvent was evaporated under reduced pressure, and benzene was added to the residue, then the insoluble content was' removed by decantation. After evaporation of the benzene solution under reduced pressure, hexane was added to the resulting solid, and the product was collected by filtration to give the title compound (4.67 g, 47percent). 1H-NMR (400 MHz, CDCl3)δ: 7.89 (1H, d, J = 2.7 Hz), 7.99-8.05 (1H, m), 8.20 (1H, d, J = 1.5 Hz). ESI-MSm/z: 111 (M+H)+.
47% With hydrazine In ethanol at 20℃; for 17 h; Heating / reflux [Referential Example 2] 2-Hydrazinopyrazine [Show Image] Hydrazine monohydrate (21.80 g) was added to 2-chloropyrazine (10.44 g) in ethanol (65 mL) at room temperature, and the resultant mixture was refluxed for 17 hours, followed by cooling in air. The reaction solvent was evaporated under reduced pressure, and then benzene was added to the residue. The resultant mixture was subjected to decantation, to thereby remove an insoluble matter. The benzene was evaporated under reduced pressure. Hexane was added to the resultant solid, and the mixture was subjected to filtration, to thereby give the title compound (4.67 g, 47percent). 1H-NMR(400MHz,CDCl3)δ:7.89(1H,d,J=2.7Hz), 7.99-8.05(1H,m), 8.20(1H,d,J=1.5Hz). ESI-MS m/z:111(M+H)+.
46% With hydrazine In ethanol at 80℃; Using Procedure AU-3 (Table 5) with 2-chloropyrazine the title compound 476 was obtained (4.4 g, 46percent) as a yellow solid. MS (m/z): 111.0 (M+H)
34% at 120℃; for 0.75 h; 20.0 g (174.6 mmol) 2-chloropyrazine are added dropwise to 60.0 ml (61.7 g, 1.2 mol) hydrazine hydrate. The mixture is stirred at a bath temperature of 120° C. for 45 min. For working up, the cooled reaction mixture is left to stand at 2° C. for 12 h, the crystals which have precipitated out are filtered off and the residue on the filter is washed twice with petroleum ether. The residue is then recrystallized from toluene.Yield: 6.5 g (34percent of th.)LC-MS (Method 1): Rt=0.49 min; MS (ESIpos): m/z=111 [M+H]+;1H-NMR (400 MHz, DMSO-d6): δ=8.11 (s, 1H), 7.94 (s, 1H), 7.90 (s, 1H), 7.70 (d, 1H), 4.29 (br. s, 2H).
34% at 120℃; for 0.75 h; 20.0 g (174.6 mmol) of chloropyrazine are added dropwise to 61.7 g (1.2 mol) of hydrazine hydrate, and the mixture is stirred at 120° C. for 45 min. The mixture is then allowed to stand at 2° C. for 24 h. The solid is filtered off and washed twice with petroleum ether. The solid is initially air-dried and then dried under high vacuum. The solid is then recrystallized from toluene and again dried under high vacuum.Yield: 6.5 g (34percent of theory)LC-MS (Method 1): Rt=0.41 min; MS (ESIpos): m/z=111 [M+H]+.

Reference: [1] Patent: WO2016/100349, 2016, A2, . Location in patent: Paragraph 0204
[2] Letters in Organic Chemistry, 2013, vol. 10, # 5, p. 348 - 352
[3] Patent: WO2013/71697, 2013, A1, . Location in patent: Paragraph 00198
[4] Patent: US2014/228361, 2014, A1, . Location in patent: Paragraph 0279-0280
[5] Patent: CN106749262, 2017, A, . Location in patent: Paragraph 0035
[6] Patent: WO2012/116276, 2012, A1, . Location in patent: Page/Page column 59
[7] ACS Medicinal Chemistry Letters, 2017, vol. 8, # 12, p. 1309 - 1313
[8] Journal of Medicinal Chemistry, 2005, vol. 48, # 1, p. 141 - 151
[9] Patent: EP1698626, 2006, A1, . Location in patent: Page/Page column 47
[10] Patent: EP1762568, 2007, A1, . Location in patent: Page/Page column 22
[11] Patent: US2017/749, 2017, A1, . Location in patent: Paragraph 0713
[12] Patent: US2010/305085, 2010, A1, . Location in patent: Page/Page column 20
[13] Patent: US2012/264704, 2012, A1, . Location in patent: Page/Page column 17
[14] ChemMedChem, 2018, vol. 13, # 10, p. 988 - 1003
[15] Journal of Medicinal Chemistry, 1988, vol. 31, # 9, p. 1719 - 1728
[16] Patent: US6316464, 2001, B1,
[17] Patent: WO2010/125102, 2010, A1, . Location in patent: Page/Page column 132
[18] Patent: WO2012/116279, 2012, A1, . Location in patent: Page/Page column 96-97
[19] Organic Process Research and Development, 2005, vol. 9, # 5, p. 634 - 639
[20] Patent: US2015/359793, 2015, A1, . Location in patent: Paragraph 0208
  • 46
  • [ 14508-49-7 ]
  • [ 68-12-2 ]
  • [ 89283-32-9 ]
YieldReaction ConditionsOperation in experiment
60 g
Stage #1: With 2,2,6,6-tetramethyl-piperidine; n-butyllithium In tetrahydrofuran at -78 - 0℃; for 0.666667 h; Inert atmosphere
Stage #2: at -78 - 70℃; for 2.16667 h; Inert atmosphere
Stage #3: With sodium tetrahydroborate In tetrahydrofuran; methanol at 20℃; for 2 h; Inert atmosphere
Under nitrogen protection,To a solution of 2,2,6,6-tetramethylpiperidine (72.8 g, 516.3 mmol)In 500 mL of dry THF solution,N-BuLi (346 mL, 553.7 mmol, 1.6 mol / L THF) was slowly added dropwise at -78 &After completion of the reaction, the reaction mixture was warmed to 0 ° C and the reaction was continued for 20 min.The reaction mixture was then cooled to -78 ° C,A solution of 2-chloropyrazine (50 g, 436.3 mmol) in THF (100 mL) was added dropwise to the reaction mixture,30min plus finished,The color of the reaction mixture changed from light yellow to dark brown,The reaction was continued for 10 min at -78-0 degC.DMF (84 ml, 1092 mmol)Was dissolved in THF (50 mL) dropwise dropwise into the reaction mixture,Control the reaction system temperature at -70 ~ -78 ,10min plus finished,The reaction was stirred at -78 ° C for 2 h.To the reaction mixture was then added MeOH (800 mL)To the reaction mixture, NaBH4 (33 g, 868 mmol) was added portionwise,After the addition, the reaction mixture was allowed to rise to room temperature and stirring continued for 2 h,TLC shows the raw material reaction is complete,The reaction solution was quenched with saturated NH4Cl,DCM (1 L x 3) was extracted three times,The organic phase was washed with water,Anhydrous Na2SO4 fully dried,After vacuum evaporation, the residue was purified by silica gel column (PE / EA = 100/1 to 5/1) to give 60 g of the title compound
Reference: [1] Patent: CN106831787, 2017, A, . Location in patent: Paragraph 0145; 0146; 0147; 0148
  • 47
  • [ 14508-49-7 ]
  • [ 5188-07-8 ]
  • [ 21948-70-9 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 5, p. 887 - 890
[2] Journal of Organic Chemistry, 2010, vol. 75, # 6, p. 2131 - 2133
  • 48
  • [ 14508-49-7 ]
  • [ 74-88-4 ]
  • [ 290-37-9 ]
  • [ 21948-70-9 ]
Reference: [1] Organic Letters, 2003, vol. 5, # 22, p. 4133 - 4136
  • 49
  • [ 14508-49-7 ]
  • [ 77287-34-4 ]
  • [ 21279-62-9 ]
  • [ 36070-79-8 ]
  • [ 21279-64-1 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1990, vol. 55, # 10, p. 2493 - 2501
[2] Collection of Czechoslovak Chemical Communications, 1990, vol. 55, # 10, p. 2493 - 2501
  • 50
  • [ 14508-49-7 ]
  • [ 77287-34-4 ]
  • [ 21279-62-9 ]
  • [ 36070-79-8 ]
  • [ 21279-64-1 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1990, vol. 55, # 10, p. 2493 - 2501
[2] Collection of Czechoslovak Chemical Communications, 1990, vol. 55, # 10, p. 2493 - 2501
  • 51
  • [ 14508-49-7 ]
  • [ 124-38-9 ]
  • [ 27398-39-6 ]
Reference: [1] Synthesis, 1988, # 11, p. 881 - 884
  • 52
  • [ 14508-49-7 ]
  • [ 75-04-7 ]
  • [ 65032-08-8 ]
Reference: [1] International Journal of Chemical Kinetics, 2000, vol. 32, # 7, p. 403 - 407
  • 53
  • [ 14508-49-7 ]
  • [ 68-12-2 ]
  • [ 121246-96-6 ]
Reference: [1] Patent: US2008/275052, 2008, A1, . Location in patent: Page/Page column 21
  • 54
  • [ 14508-49-7 ]
  • [ 107-31-3 ]
  • [ 121246-96-6 ]
Reference: [1] Patent: WO2005/113535, 2005, A2, . Location in patent: Page/Page column 24
  • 55
  • [ 14508-49-7 ]
  • [ 109-94-4 ]
  • [ 121246-96-6 ]
Reference: [1] Synthesis, 1988, # 11, p. 881 - 884
  • 56
  • [ 14508-49-7 ]
  • [ 59016-93-2 ]
  • [ 127406-08-0 ]
YieldReaction ConditionsOperation in experiment
90% With C46H49BrClFeN3Pd; copper diacetate; caesium carbonate In 1,4-dioxane at 110℃; for 24 h; General procedure: A 10 mL round-bottom flask was charged with the prescribedamount of catalyst Pd/Cu, aryl chlorides (0.5 mmol), phenylboronicacids containing hydroxymethyl (0.75 mmol), Cs2CO3 (1.0 mmol)and dioxane (5 mL) in air. The reaction mixture was then placedin an oil bath and heated at 110 C for 24 h. After removal of thesolvent, the resulting residue was purified by flash chromatographyon silica gel using CH2Cl2 as eluent. The products 4a–k, and4m are known compounds [6,9] except for 4l and 4n.
90% With C46H49BrClFeN3Pd; copper diacetate; caesium carbonate In 1,4-dioxane at 110℃; for 24 h; General procedure: A 10 mL round-bottom flask was charged with the prescribedamount of catalyst Pd/Cu, aryl chlorides (0.5 mmol), phenylboronicacids containing hydroxymethyl (0.75 mmol), Cs2CO3 (1.0 mmol)and dioxane (5 mL) in air. The reaction mixture was then placedin an oil bath and heated at 110 C for 24 h. After removal of thesolvent, the resulting residue was purified by flash chromatographyon silica gel using CH2Cl2 as eluent. The products 4a–k, and4m are known compounds [6,9] except for 4l and 4n.
90% With C46H49BrClFeN3Pd; copper diacetate; caesium carbonate In 1,4-dioxane at 110℃; for 24 h; General procedure: A 10 mL round-bottom flask was charged with the prescribedamount of catalyst Pd/Cu, aryl chlorides (0.5 mmol), phenylboronicacids containing hydroxymethyl (0.75 mmol), Cs2CO3 (1.0 mmol)and dioxane (5 mL) in air. The reaction mixture was then placedin an oil bath and heated at 110 C for 24 h. After removal of thesolvent, the resulting residue was purified by flash chromatographyon silica gel using CH2Cl2 as eluent. The products 4a–k, and4m are known compounds [6,9] except for 4l and 4n.
Reference: [1] Inorganica Chimica Acta, 2014, vol. 423, # PART A, p. 11 - 15
[2] Inorganica Chimica Acta, 2014, vol. 423, # 1, p. 11 - 15
[3] Inorganica Chimica Acta, 2014, # PA, p. 11 - 15
  • 57
  • [ 14508-49-7 ]
  • [ 87199-17-5 ]
  • [ 127406-08-0 ]
YieldReaction ConditionsOperation in experiment
97% With sodium carbonate In ethanol; toluene for 18 h; Heating / reflux Step A
Ethanol (13 ml) and 1.0M Na2CO3 (27.5 ml) were added to a suspension of 2-chloropyrazine (4.0 g, 34.6 mmole), 4-formylphenylboronic acid (6.8 g, 45.0 mmole), and tetrakis(triphenylphosphine)palladium(0) (2.0 g, 1.7 mmole) in toluene (55 ml).
The mixture was refluxed for 18 hours then cooled, diluted with EtOAc, washed with NaHCO3, washed with brine, dried (MgSO4) and concentrated.
Purification by chromatography (SiO2, 4:1 hexanes/EtOAc) yielded 6.2 g (97percent) of 4-(2-pyrazinyl)benzaldehyde.
42%
Stage #1: With sodium carbonate In ethanol; water; toluene for 18 h; Heating / reflux
Stage #2: With sodium hydrogencarbonate In ethanol; water; ethyl acetate; toluene
[0410] Step A: [0411] 1M aq. Na2CO3 (20 mL) and ethanol (10 mL) were added to a solution of 2-chloropyrazine (2.30 g, 20.06 mmol), 4-formylphenylboronic acid (3.90 g, 26.01 mmol) and [1,4-bis(diphenylphosphino)butane]palladium(II) dichloride (0.60 g, 0.99 mmol) in toluene (40 mL) and the mixture was heated to reflux for 18 h. The cooled reaction mixture was diluted with ethyl acetate, washed with sat. aq. NaHCO3 and brine, dried (MgSO4), and concentrated. Purification by chromatography (SiO2, 4:1 hexane/ethyl acetate) yielded 1.56 g (42percent) of 4-pyrazinylbenzaldehyde.
Reference: [1] Patent: US2005/250713, 2005, A1, . Location in patent: Page/Page column 29-30
[2] Organic and Biomolecular Chemistry, 2014, vol. 12, # 35, p. 6944 - 6952
[3] Patent: US2004/18994, 2004, A1, . Location in patent: Page/Page column 61
  • 58
  • [ 14508-49-7 ]
  • [ 3034-50-2 ]
  • [ 503176-43-0 ]
Reference: [1] Patent: US2003/125267, 2003, A1,
  • 59
  • [ 14508-49-7 ]
  • [ 128796-39-4 ]
  • [ 380626-88-0 ]
Reference: [1] Organic Letters, 2016, vol. 18, # 13, p. 3082 - 3085
[2] Patent: WO2007/125364, 2007, A1, . Location in patent: Page/Page column 48
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 14508-49-7 ]

Chlorides

Chemical Structure| 33332-29-5

[ 33332-29-5 ]

2-Amino-5-chloropyrazine

Similarity: 0.78

Chemical Structure| 19745-07-4

[ 19745-07-4 ]

2,5-Dichloropyrazine

Similarity: 0.76

Chemical Structure| 912773-21-8

[ 912773-21-8 ]

2-Bromo-5-chloropyrazine

Similarity: 0.74

Chemical Structure| 32493-79-1

[ 32493-79-1 ]

2,3-Dichloro-5,6-dimethylpyrazine

Similarity: 0.74

Chemical Structure| 4774-14-5

[ 4774-14-5 ]

2,6-Dichloropyrazine

Similarity: 0.74

Related Parent Nucleus of
[ 14508-49-7 ]

Pyrazines

Chemical Structure| 33332-29-5

[ 33332-29-5 ]

2-Amino-5-chloropyrazine

Similarity: 0.78

Chemical Structure| 19745-07-4

[ 19745-07-4 ]

2,5-Dichloropyrazine

Similarity: 0.76

Chemical Structure| 912773-21-8

[ 912773-21-8 ]

2-Bromo-5-chloropyrazine

Similarity: 0.74

Chemical Structure| 32493-79-1

[ 32493-79-1 ]

2,3-Dichloro-5,6-dimethylpyrazine

Similarity: 0.74

Chemical Structure| 4774-14-5

[ 4774-14-5 ]

2,6-Dichloropyrazine

Similarity: 0.74